Tecarfarin Anti-Coagulation Trial (TACT)

NCT02522221 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Thromboembolism
Thrombosis

Interventions

DRUG: Warfarin
DRUG: tecarfarin

Sponsor

Espero Biopharma